New vaccine aims to control or cure chronic hepatitis b
Disease control
Not yet recruiting
This early-stage trial tests a new therapeutic vaccine (Hepadvax) in 40 adults with chronic hepatitis B. The vaccine is designed to boost the immune system to control or possibly clear the virus. Researchers will monitor safety, viral load, and immune responses compared to a stan…
Phase: PHASE1, PHASE2 • Sponsor: Vaxine Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC